POLARIS SPECIALTY PHARMACY, LLC – Trademark Portfolio
Entity Type: 16
POLARIS SPECIALTY PHARMACY, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PREMIER PHARMACY SERVICES. The owner is based in LOS ANGELES, CA.
10880 WILSHIRE BOULEVARD
LOS ANGELES, CA 90024
Showing of trademarks Trademarks
Trademark Classifications
POLARIS SPECIALTY PHARMACY, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does POLARIS SPECIALTY PHARMACY, LLC have?
POLARIS SPECIALTY PHARMACY, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does POLARIS SPECIALTY PHARMACY, LLC file in?
POLARIS SPECIALTY PHARMACY, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 39 (Transportation & Storage). Class 35 covers advertising; business management; business administration; office functions.
What are POLARIS SPECIALTY PHARMACY, LLC's most well-known trademarks?
POLARIS SPECIALTY PHARMACY, LLC's registered trademark portfolio includes well-known marks such as PREMIER PHARMACY SERVICES. These are among 1 currently registered trademark in the portfolio.
What is POLARIS SPECIALTY PHARMACY, LLC's trademark registration success rate?
POLARIS SPECIALTY PHARMACY, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.